Genfit Stock Forecast, Price & News

Genfit (NASDAQ:GNFT) Frequently Asked Questions

Is Genfit a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Genfit in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Genfit stock.
View analyst ratings for Genfit or view top-rated stocks.

How has Genfit's stock price been impacted by COVID-19 (Coronavirus)?

Genfit's stock was trading at $14.23 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, GNFT shares have decreased by 67.9% and is now trading at $4.57.
View which stocks have been most impacted by COVID-19.

When is Genfit's next earnings date?

Genfit is scheduled to release its next quarterly earnings announcement on Thursday, April 7th 2022.
View our earnings forecast for Genfit.

What price target have analysts set for GNFT?

4 brokerages have issued 1 year target prices for Genfit's stock. Their forecasts range from $8.00 to $15.00. On average, they anticipate Genfit's stock price to reach $11.50 in the next twelve months. This suggests a possible upside of 151.6% from the stock's current price.
View analysts' price targets for Genfit or view top-rated stocks among Wall Street analysts.

Who are Genfit's key executives?

Genfit's management team includes the following people:

• Pascal Prigent, CEO & EVP-Marketing & Development
• Dean W. Hum, Chief Operating Officer
• Thomas Baetz, Chief Financial Officer
• Carol L. Addy, Chief Medical Officer
• Stefanie Magner, Chief Compliance Officer

What is Jean-François Mouney's approval rating as Genfit's CEO?

3 employees have rated Genfit CEO Jean-François Mouney on Glassdoor.com. Jean-François Mouney has an approval rating of 29% among Genfit's employees. This puts Jean-François Mouney in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Genfit's key competitors?

Some companies that are related to Genfit include Molecular Partners (MOLN), Sangamo Therapeutics (SGMO), Immunocore (IMCR), Immunovant (IMVT), SOPHiA Genetics (SOPH), Ocugen (OCGN), MeiraGTx (MGTX), Agenus (AGEN), Century Therapeutics (IPSC), Immatics (IMTX), Rubius Therapeutics (RUBY), Caribou Biosciences (CRBU), Monte Rosa Therapeutics (GLUE), Vaxart (VXRT) and Osiris Therapeutics (OSIR).
View all of GNFT's competitors.

What other stocks do shareholders of Genfit own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Genfit investors own include Intercept Pharmaceuticals (ICPT), InterDigital (IDCC), STAG Industrial (STAG), Gilead Sciences (GILD), Occidental Petroleum (OXY), Vaxart (VXRT), Exxon Mobil (XOM), Zynerba Pharmaceuticals (ZYNE), Aimmune Therapeutics (AIMT) and Amarin (AMRN).

When did Genfit IPO?

(GNFT) raised $132 million in an IPO on Wednesday, March 27th 2019. The company issued 5,000,000 shares at $26.33 per share. SVB Leerink and Barclays served as the underwriters for the IPO and Bryan, Garnier, Natixis, Roth Capital Partners and H.C. Wainwright & Co. were co-managers.

What is Genfit's stock symbol?

Genfit trades on the NASDAQ under the ticker symbol "GNFT."

How do I buy shares of Genfit?

Shares of GNFT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Genfit's stock price today?

One share of GNFT stock can currently be purchased for approximately $4.57.

How much money does Genfit make?

Genfit has a market capitalization of $227.65 million and generates $8.86 million in revenue each year.

How many employees does Genfit have?

Genfit employs 130 workers across the globe.

What is Genfit's official website?

The official website for Genfit is www.genfit.com.

Where are Genfit's headquarters?

Genfit is headquartered at PARC 885 AVENUE EUGENE AVINEE, LOOS I0, 59120.

How can I contact Genfit?

Genfit's mailing address is PARC 885 AVENUE EUGENE AVINEE, LOOS I0, 59120. The company can be reached via phone at (332) 016-4000 or via email at [email protected].